BASF bids €664m for omega-3 company


BASF is to spend €664 million (£530 million) to buy Norwegian firm Pronova BioPharma, which specialises in omega-3 fatty acids. It has the backing of the Pronova board and shareholders representing 60% of the company, including private equity fund Herkules, which owns a 50% stake.

Pronova makes active pharmaceutical ingredients based on omega-3 fatty acids that are used to treat cardiovascular conditions. It also makes dietary supplements.

BASF says that omega-3 fatty acids represent a growing market. The company gained a significant stake in the market through its €3.1 billion purchase of german speciality chemical company Cognis in 2010. It strengthened its position in May this year when it bought UK firm Equateq.

Pronova employs 300 people and makes annual sales of about NOK1.7 billion (£180 million).


Related Content

BASF ups Pronova bid

16 January 2013 Business

news image

Pronova BioPharma specialises in omega-3 fatty acids

Lean green microbe machines

30 April 2013 Feature

news image

For its proponents, algae hold the promise of a clean source of fuel, food or drugs. Anthony King wades in

Most Commented

How to print a crystal in 3D

17 April 2014 Research

news image

Rather than looking at a crystal on a screen, print it out and hold it in your hand

The sultan of synthesis

11 April 2014 Feature

news image

Phil Baran is spurring organic chemists to rethink how they make complex compounds, as Mark Peplow discovers